TrialTrials2017
Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial.
Chris Smith et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it